Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure

Dulce Gonzalez (Ciudad de Mexico, Mexico), Rafael Hernández-Zenteno, Brenda Santellano-Juárez, Arturo Orea-Tejeda, Dulce Gonzalez, Juan Pineda-Juárez, Rocío Sánchez-Santillán, Viridiana Peláez-Hernández, Alejandra Velázquez-Montero, Carlos Cíntora-Martínez, Raúl Herrera-Saucedo, Elisa Pérez-Cabañas, Edna Contreras-Ramírez, Raúl Sansores-Martínez

Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Session: Comorbidities and exacerbations in COPD
Session type: Thematic Poster
Number: 1130

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dulce Gonzalez (Ciudad de Mexico, Mexico), Rafael Hernández-Zenteno, Brenda Santellano-Juárez, Arturo Orea-Tejeda, Dulce Gonzalez, Juan Pineda-Juárez, Rocío Sánchez-Santillán, Viridiana Peláez-Hernández, Alejandra Velázquez-Montero, Carlos Cíntora-Martínez, Raúl Herrera-Saucedo, Elisa Pérez-Cabañas, Edna Contreras-Ramírez, Raúl Sansores-Martínez. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure. Eur Respir J 2016; 48: Suppl. 60, 1130

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006



Cardiovascular comorbidities in chronic obstructive pulmonary disease patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017

The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016

Prevalence of comorbidity in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012


Features of clinical cours of chronic obstructive pulmonary disease and ischemic heart disease in case of comorbidity
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012



Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012



Characteristics and comorbidities associated with pain in people with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


Association between arterial stiffness and acute exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013